Media Center

Publications Presentations Media Blog
State Medical Board Actions and the Standard of Care for Prescribing hGH
April 2014
E-Journal of Age Management Medicine

Many physicians who prescribe Human Growth Hormone (“hGH”) focus on the legal risks imposed by the Federal Food, Drug, and Cosmetic Act (“FDCA”) because that law imposes felony sanctions on the distribution of hGH for off-label purposes. However, state medical boards have been more aggressive than the federal government in taking action against physicians for prescribing hGH for such purposes. Because the legal terrain has changed over the last few years, physicians should exercise great caution when prescribing hGH, especially for adult hGH deficiency (“AGHD”). This article briefly summarizes the diverse status of hGH in the states and provides a few examples of actions state medical boards have taken against physicians for prescribing hGH.

Full Article


Practice Areas